Involvement of the serotoninergic system in the mechanism of action of ultralow dose antibodies to S-100 protein.

Autor: Kheifets IA; Materia Medica Holding, Moscow, Russia. heifezia@materiamedica.ru, Dugina YL, Voronina TA, Molodavkin GM, Martyushev-Poklad AV, Sergeeva SA, Epstein OI
Jazyk: angličtina
Zdroj: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2007 May; Vol. 143 (5), pp. 598-600.
DOI: 10.1007/s10517-007-0191-y
Abstrakt: The involvement of the serotoninergic system in the realization of anxiolytic and antidepressant activities of antibodies to S-100 protein in ultralow doses is proven. Administration of ultralow-dose antibodies to S-100 protein in combination with serotoninergic agents (ketanserin and 5-hydroxytryptophan) reduced the anxiolytic and antidepressant effects of antibodies.
Databáze: MEDLINE
Externí odkaz: